Delisting risk
Lakewood-Amedex Biotherapeutics
Develops topical Nu-3 gel for mildly infected diabetic foot ulcers.
$2.96
Pre-market+0.45 (+17.93%)
At close$2.51(+9.13%)
Something off on this page? Send us feedback.
EPSReportedEstimate
——————May '26Aug '26
Reported——————−$1.32−$2.75
Estimate———————$0.65
Surprise———————−523.1%
RevenueReportedEstimate
——————May '26Aug '26
Reported————————
Estimate————————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Aug 2026 | $0.65 | −$2.75 | −523.1% |
| May 2026 | — | −$1.32 | — |
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | $0.65 | −$2.75 | −523.1% | — | — | — | −1.3% |
| May 22, 2026 | — | −$1.32 | — | — | — | — | +0.7% |